DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c67215) has announced the addition of Medical Affairs Excellence: Structuring, Funding, & Aligning for Global Success to their offering.
In today's challenging healthcare environment, medical affairs' role has become even more crucial to pharmaceutical companies' success. Confronted with declining R&D productivity, escalating development costs, increasing competition, growing price pressures and intensified regulatory and public scrutiny, pharmaceutical companies seek to maintain double-digit revenue and earnings growth demanded by investors. In addition, companies are reallocating resources in response to Office of Inspector General (OIG) guidelines. This study uncovers how leading companies are working to align, staff and fund medical affairs capabilities to respond to these challenges.
Most Popular Articles in Business
Most Popular Publications in Business |
Measuring Performance
Medical Affairs Performance Measures
* Overall Medical Affairs Staffing Levels
* Staffing by Capabilities
* Imputed FTEs Per Dedicated MA Capability
* FTEs to # of Compounds
* FTEs to # of Therapy Areas
* FTEs to U.S. Sales
* Staffing Changes and Drivers
* Outsourcing: Company
* Outsourcing: Capability
* External Spend Average and Range
advertisement
* External Spend: Average By Capability
* External Spend Per Compound
* Source and Distribution of Spend
* Factors Driving High Resource Consumption
Staffing and Spend
* Introduction
* Mission, Roles, & Responsibilities
* Geographic Span of Responsibility
* Product Lifecycle Span of Responsibility
* Functional Components and Structure
* Cross-Functional Interfaces
* Organizational Structures and Processes
Appendix
* Glossary of Terms
For more information visit http://www.researchandmarkets.com/reports/c67215
COPYRIGHT 2007 Business Wire
COPYRIGHT 2007 Gale Group
Tidak ada komentar:
Posting Komentar